These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 34229529)
1. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series. Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529 [TBL] [Abstract][Full Text] [Related]
2. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations. Myles N; Myles H; Clark SR; Bird R; Siskind D Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065 [TBL] [Abstract][Full Text] [Related]
3. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review. Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489 [TBL] [Abstract][Full Text] [Related]
4. Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series. Béchard L; Morasse-Bégis M; Corbeil O; Hakim JR; Malenfant E; Brodeur S; Huot-Lavoie M; Essiambre AM; Demers MF; Roy MA J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):391-395. PubMed ID: 35546087 [TBL] [Abstract][Full Text] [Related]
5. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review]. Simon L; Cazard F Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327 [TBL] [Abstract][Full Text] [Related]
6. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report]. Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674 [TBL] [Abstract][Full Text] [Related]
7. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report. Chan KSW; Lai NBW; Wong MMC; Pang PF East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553 [TBL] [Abstract][Full Text] [Related]
8. Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review. Corbeil O; Béchard L; Fournier É; Plante M; Thivierge MA; Lafrenière CÉ; Huot-Lavoie M; Brodeur S; Essiambre AM; Roy MA; Demers MF J Psychopharmacol; 2023 Apr; 37(4):370-377. PubMed ID: 36794520 [TBL] [Abstract][Full Text] [Related]
9. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis. Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037 [TBL] [Abstract][Full Text] [Related]
10. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use. Demers MF; Fortier L; Corbeil O; Breault AS; Roy MA Asian J Psychiatr; 2020 Feb; 48():101541. PubMed ID: 30314715 [No Abstract] [Full Text] [Related]
12. Clozapine re-challenge under the cover of Filgrastim. Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060 [TBL] [Abstract][Full Text] [Related]
13. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis. Hazewinkel AW; Bogers JP; Giltay EJ Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report. Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015 [TBL] [Abstract][Full Text] [Related]
15. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine. Kolli V; Denton K; Borra D; Pulluri M; Sharma A Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755 [TBL] [Abstract][Full Text] [Related]
16. Use of cytokines in clozapine-induced agranulocytosis. Chin-Yee I; Bezchlibnyk-Butler K; Wong L Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147 [TBL] [Abstract][Full Text] [Related]
17. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy. Lertxundi U; Sanchez P; Hernandez R; Elizagarate E J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024 [No Abstract] [Full Text] [Related]
18. Clozapine rechallenge and initiation despite neutropenia- a practical, step-by-step guide. Silva E; Higgins M; Hammer B; Stephenson P BMC Psychiatry; 2020 Jun; 20(1):279. PubMed ID: 32503471 [TBL] [Abstract][Full Text] [Related]
19. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride). Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914 [No Abstract] [Full Text] [Related]
20. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine. Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]